Circulating levels of dickkopf-1, osteoprotegerin and sclerostin are higher in old compared with young men and women and positively associated with whole-body bone mineral density in older adults

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Osteoporosis International

• Publication date

  2017-06-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00198-017-4104-2PMID 28585053
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impaired bone remodeling in children with osteogenesis imperfecta treated and untreated with bisphosphonates: the role of DKK1, RANKL, and TNF-α

  2016cited by this paper
• Sclerostin and DKK-1: two important regulators of bone metabolism in HIV-infected youths

  2015cited by this paper
• Functional Diversity of Fibroblast Growth Factors in Bone Formation

  2015cited by this paper
• Effects of age on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in humans.

  2014cited by this paper
• Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study

  2013cited by this paper
• The Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis

  2013cited by this paper
• Physiological and functional evaluation of healthy young and older men and women: design of the European MyoAge study

  2013cited by this paper
• Correlates of bone microarchitectural parameters and serum sclerostin levels in men: The STRAMBO study

  2013cited by this paper
• Sclerostin and bone strength in women in their 10th decade of life

  2013cited by this paper
• The role of BMPs in bone anabolism and their potential targets SOST and DKK1.

  2012cited by this paper
• Update on Wnt signaling in bone cell biology and bone disease.

  2012cited by this paper
• Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases.

  2012cited by this paper
• The role of Dkk1 in bone mass regulation: Correlating serum Dkk1 expression with bone mineral density

  2011cited by this paper
• Diagnostic Utility of Osteocalcin, Undercarboxylated Osteocalcin, and Alkaline Phosphatase for Osteoporosis in Premenopausal and Postmenopausal Women

  2011cited by this paper
• Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women—the six-month effect of risedronate and teriparatide

  2011cited by this paper
• Osteoprotegerin, RANKL and bone turnover in postmenopausal osteoporosis

  2011cited by this paper
• Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss.

  2010cited by this paper
• Regulation of Circulating Sclerostin Levels by Sex Steroids in Women and in Men

  2010cited by this paper
• Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism.

  2010cited by this paper
• Relation of Age, Gender, and Bone Mass to Circulating Sclerostin Levels in Women and Men

  2010cited by this paper
• Sclerostin: Current Knowledge and Future Perspectives

  2010cited by this paper
• Does standardized BMD still remove differences between Hologic and GE-Lunar state-of-the-art DXA systems?

  2009cited by this paper
• Increased plasma osteoprotegerin concentrations are associated with indices of bone strength of the hip.

  2008cited by this paper
• The sex-specific association of serum osteoprotegerin and receptor activator of nuclear factor kappaB legend with bone mineral density in older adults: the Rancho Bernardo study.

  2007cited by this paper
• Increased serum osteoprotegerin values in long-lived subjects: different effects of inflammation and bone metabolism.

  2006cited by this paper
• Clinical Investigations Relationships Between the Changes of Serum Levels of OPG and RANKL with Age, Menopause, Bone Biochemical Markers and Bone Mineral Density in Chinese Women Aged 20-75

  2005cited by this paper
• Circulating osteoprotegerin and receptor activator of NF‐κB ligand system are associated with bone metabolism in middle‐aged males

  2005cited by this paper
• Relationships Between the Changes of Serum Levels of OPG and RANKL with Age, Menopause, Bone Biochemical Markers and Bone Mineral Density in Chinese Women Aged 20-75

  2004cited by this paper
• Role of osteopontin in adhesion, migration, cell survival and bone remodeling.

  2004cited by this paper
• Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice.

  2003cited by this paper
• Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women.

  2002cited by this paper
• Interim Report and Recommendations of the World Health Organization Task-Force for Osteoporosis

  1999cited by this paper
• Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells.

  1999cited by this paper

• Immunological factors, bone and lean tissue status in patients with rheumatoid arthritis

  2025cites this paper
• TRIM21 contributes to senile osteoporosis by shifting the osteoadipogenic balance toward adipogenesis in BMSCs

  2025cites this paper
• The role of osteoprotegerin (OPG) in exercise-induced skeletal muscle adaptation

  2024cites this paper
• Plasma proteomic profiles reveal proteins and three characteristic patterns associated with osteoporosis: A prospective cohort study

  2024cites this paper
• Emerging roles of osteocytes in regulation of bone and skeletal muscle mass.

  2024cites this paper
• Correlation between body composition and bone mineral density differs by sex and skeletal site in overweight and obese Chinese subjects.

  2024cites this paper
• Exploring the Role of Hormones and Cytokines in Osteoporosis Development

  2024cites this paper
• Albumin-to-alkaline phosphatase ratio may be a better predictor of survival than sclerostin, dickkopf-1, osteopontin, osteoprotegerin and osteocalcin

  2024cites this paper
• Regulatory cellular and molecular networks in the bone microenvironment during aging

  2024cites this paper
• Sclerostin and OPG/RANK-L system take part in bone remodeling in patients with acromegaly

  2024cites this paper
• Influence of Muscle Mass and Strength on Bone Mineralisation with Consideration of Sclerostin Concentration

  2023cites this paper
• Sex Differences in Bone, Muscle, and Inflammatory Markers and Their Associations with Muscle Performance Variables

  2023cites this paper
• Fibroblast growth factor 23 and its role in bone diseases

  2023cites this paper
• Effects of an Intervention with Selenium and Coenzyme Q10 on Five Selected Age-Related Biomarkers in Elderly Swedes Low in Selenium: Results That Point to an Anti-Ageing Effect—A Sub-Analysis of a Previous Prospective Double-Blind Placebo-Controlled Randomised Clinical Trial

  2023cites this paper
• The WNT/β-catenin system in chronic kidney disease-mineral bone disorder syndrome

  2023cites this paper
• Clinical Data for Parametrization of In Silico Bone Models Incorporating Cell-Cytokine Dynamics: A Systematic Review of Literature

  2022influential citation
• Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities

  2022cites this paper
• Serum sclerostin levels in osteoporotic fracture patients

  2022cites this paper
• Wnt signaling pathway inhibitors, sclerostin and DKK-1, correlate with pain and bone pathology in patients with Gaucher disease

  2022cites this paper
• Differential Expression of Dickkopf 1 and Periostin in Mouse Strains with High and Low Bone Mass

  2022influential citation
• Serum concentrations of osteoprotegerin, brain-derived nerve factor, angiotensin II, and endothelin-1 in aging dogs

  2022cites this paper
• Sclerostin and Dickkopf-1 Characteristics According to Age and Physical Activity Levels in Premenopausal Women.

  2021cites this paper
• Cytokines and the pathogenesis of osteoporosis

  2021cites this paper
• RhoA/Rock activation represents a new mechanism for inactivating Wnt/β-catenin signaling in the aging-associated bone loss

  2021influential citation
• Biomarkers of Ageing in Dogs

  2021influential citation
• Assessment of Serum sRANKL, sRANKL/OPG Ratio, and Other Bone Turnover Markers with the Estimated 10-Year Risk of Major and Hip Osteoporotic Fractures in Rheumatoid Arthritis: A Cross-Sectional Study

  2021cites this paper
• Sclerostin and Its Associations With Bone Metabolism Markers and Sex Hormones in Healthy Community-Dwelling Elderly Individuals and Adolescents

  2020cites this paper
• Cytokines and Bone: Osteoimmunology.

  2020cites this paper
• Associations of serum sclerostin with bone mineral density, markers of bone metabolism and thalassaemia characteristics in adult patients with transfusion-dependent beta-thalassaemia

  2020cites this paper
• Osteokines and Bone Markers at Rest and following Plyometric Exercise in Pre- and Postmenopausal Women

  2020cites this paper
• Sclerostin expression in trabecular bone is downregulated by osteoclasts

  2020cites this paper
• Association Between FGF-23 Levels and Risk of Fracture in Women With Systemic Sclerosis.

  2020cites this paper
• A Review of the Potential Application of Osteocyte-Related Biomarkers, Fibroblast Growth Factor-23, Sclerostin, and Dickkopf-1 in Predicting Osteoporosis and Fractures

  2020influential citation
• Comparison of Muscle Function, Bone Mineral Density and Body Composition of Early Starting and Later Starting Older Masters Athletes

  2019cites this paper
• Perinatal sclerostin concentrations in abnormal fetal growth: the impact of gestational diabetes

  2019cites this paper
• Association of serum bone- and muscle-derived factors with age, sex, body composition, and physical function in community-dwelling middle-aged and elderly adults: a cross-sectional study

  2019cites this paper
• The effect of plyometric exercise on bone turnover markers and osteokines in younger and older women

  2018cites this paper
• Therapeutic targets of osteoporosis: correlation of age, body mass index, blood glucose and blood lipids with sclerostin and DKK‐1

  2018cites this paper